These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9670612)
1. Saporin immunotoxins. Flavell DJ Curr Top Microbiol Immunol; 1998; 234():57-61. PubMed ID: 9670612 [No Abstract] [Full Text] [Related]
2. Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation. Tazzari PL; Bolognesi A; de Totero D; Falini B; Lemoli RM; Soria MR; Pileri S; Gobbi M; Stein H; Flenghi L Br J Haematol; 1992 Jun; 81(2):203-11. PubMed ID: 1322690 [TBL] [Abstract][Full Text] [Related]
3. Intra-thecal treatment of leptomeningeal lymphoma with immunotoxin. Urch CE; George AJ; Stevenson GT; Bolognesi A; Stirpe F; Weller R; Glennie MJ Int J Cancer; 1991 Apr; 47(6):909-15. PubMed ID: 2010234 [TBL] [Abstract][Full Text] [Related]
4. Comparison of immunotoxins bearing a single saporin molecule with multiple toxin conjugates. Flavell DJ; Flavell SU Methods Mol Biol; 2001; 166():87-100. PubMed ID: 11217378 [No Abstract] [Full Text] [Related]
5. Systemic therapy with 3BIT, a triple combination cocktail of anti-CD19, -CD22, and -CD38-saporin immunotoxins, is curative of human B-cell lymphoma in severe combined immunodeficient mice. Flavell DJ; Noss A; Pulford KA; Ling N; Flavell SU Cancer Res; 1997 Nov; 57(21):4824-9. PubMed ID: 9354445 [TBL] [Abstract][Full Text] [Related]
6. Response of B-cell lymphoma to a combination of bispecific antibodies and saporin. French RR; Bell AJ; Hamblin TJ; Tutt AL; Glennie MJ Leuk Res; 1996 Jul; 20(7):607-17. PubMed ID: 8795695 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line. Flavell DJ; Cooper S; Okayama K; Emery L; Flavell SU Hematol Oncol; 1995; 13(4):185-200. PubMed ID: 7557895 [TBL] [Abstract][Full Text] [Related]
8. Augmented inhibition of tumor cell proliferation in combined use of electroporation with a plant toxin, saporin. Mashiba H; Ozaki Y; Matsunaga K Ann N Y Acad Sci; 1999; 886():233-5. PubMed ID: 10667227 [No Abstract] [Full Text] [Related]
9. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. Terenzi A; Bolognesi A; Pasqualucci L; Flenghi L; Pileri S; Stein H; Kadin M; Bigerna B; Polito L; Tazzari PL; Martelli MF; Stirpe F; Falini B Br J Haematol; 1996 Mar; 92(4):872-9. PubMed ID: 8616080 [TBL] [Abstract][Full Text] [Related]
10. Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo. French RR; Courtenay AE; Ingamells S; Stevenson GT; Glennie MJ Cancer Res; 1991 May; 51(9):2353-61. PubMed ID: 2015599 [TBL] [Abstract][Full Text] [Related]
11. Selective killing of CD4+ and CD8+ cells with immunotoxins containing saporin. Barbieri L; Bolognesi A; Dinota A; Lappi DA; Soria M; Tazzari PL; Stirpe F Scand J Immunol; 1989 Sep; 30(3):369-72. PubMed ID: 2571186 [TBL] [Abstract][Full Text] [Related]
12. Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin. French RR; Hamblin TJ; Bell AJ; Tutt AL; Glennie MJ Lancet; 1995 Jul; 346(8969):223-4. PubMed ID: 7542357 [TBL] [Abstract][Full Text] [Related]
13. Loss of nerve: a molecular approach to better treatment of chronic pain. Friedrich MJ JAMA; 2000 Jan; 283(2):187-8. PubMed ID: 10634324 [No Abstract] [Full Text] [Related]
14. Neuropeptide-toxin conjugates in pain research and treatment. Wiley RG Reg Anesth Pain Med; 2000; 25(5):546-8. PubMed ID: 11009244 [No Abstract] [Full Text] [Related]
15. Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein from Saponaria officinalis. Stirpe F; Derenzini M; Barbieri L; Farabegoli F; Brown AN; Knowles PP; Thorpe PE Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(5):259-71. PubMed ID: 2889289 [TBL] [Abstract][Full Text] [Related]
16. Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: in vitro results and in vivo effects in an acute rejection model. Tazzari PL; Polito L; Bolognesi A; Pistillo MP; Capanni P; Palmisano GL; Lemoli RM; Curti A; Biancone L; Camussi G; Conte R; Ferrara GB; Stirpe F J Immunol; 2001 Oct; 167(8):4222-9. PubMed ID: 11591743 [TBL] [Abstract][Full Text] [Related]
17. Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma. Glennie MJ; Brennand DM; Bryden F; McBride HM; Stirpe F; Worth AT; Stevenson GT J Immunol; 1988 Nov; 141(10):3662-70. PubMed ID: 3141503 [TBL] [Abstract][Full Text] [Related]
18. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688 [TBL] [Abstract][Full Text] [Related]
19. Ribosome-inactivating proteins from plants inhibit ribosome activity of Trypanosoma and Leishmania. Cenini P; Bolognesi A; Stirpe F J Protozool; 1988 Aug; 35(3):384-7. PubMed ID: 3183997 [TBL] [Abstract][Full Text] [Related]